Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/13/2012US8309591 Transmucosal veterinary composition comprising detomidine
11/13/2012US8309590 Triazol compounds for treating biofilm formation
11/13/2012US8309589 Fluorine-containing organosulfur compound and pesticidal composition comprising the same
11/13/2012US8309588 Synergistic microbicidal compositions
11/13/2012US8309587 Piperidine and piperazine phenyl sulphonamides as modulators of ion channels
11/13/2012US8309586 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
11/13/2012US8309584 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists
11/13/2012US8309583 Desferrioxamine conjugates, derivatives and analogues
11/13/2012US8309582 Small molecule Bcl-Xl/Bcl-2 binding inhibitors
11/13/2012US8309581 Benzimidazole derivatives
11/13/2012US8309580 Heterocyclic compound
11/13/2012US8309579 N-hydroxyamide derivatives and use thereof
11/13/2012US8309578 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
11/13/2012US8309577 Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
11/13/2012US8309576 Method of treating inflammatory bowel disease
11/13/2012US8309575 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
11/13/2012US8309574 Nuclear transfer promoter for Rac protein and method of screening the same
11/13/2012US8309573 Salt of isoquinoline compound and crystal thereof
11/13/2012US8309572 Muscarinic acetylcholine receptor antagonists
11/13/2012US8309571 Heterobicyclic compounds useful as kinase inhibitors
11/13/2012US8309570 E.g., dextromethorphan hydrobromide, amantadine, memantine, remacemide or riluzole; treating pain resulting from injury, trauma, lesion or other disorders in the spinal cord or brain
11/13/2012US8309569 Methods for treating diarrhea-associated irritable bowel syndrome
11/13/2012US8309568 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
11/13/2012US8309567 Spiroindoline derivatives having insecticidal properties
11/13/2012US8309566 Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
11/13/2012US8309565 Phosphonate compounds
11/13/2012US8309564 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
11/13/2012US8309563 Quinazoline derivatives useful as anti-tumor medicament
11/13/2012US8309562 Compounds and therapeutical use thereof
11/13/2012US8309561 Phenylalanine derivatives
11/13/2012US8309560 Methods and compositions for ameliorating the undesirable effects of chemotherapy
11/13/2012US8309559 (EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof
11/13/2012US8309558 Compounds for the treatment of hepatitis C
11/13/2012US8309555 Compositions and methods for inducing cell dedifferentiation
11/13/2012US8309554 Hypoxia activated drugs of nitrogen mustard alkylators
11/13/2012US8309553 Anhydrous crystal form of ovrepitant maleate
11/13/2012US8309552 Immunomodulating heterocyclic compounds
11/13/2012US8309551 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
11/13/2012US8309550 Kinase inhibitors and their use as pharmaceutical agents
11/13/2012US8309549 Compositions for modulating a kinase cascade and methods of use thereof
11/13/2012US8309548 Benzene, pyridine, and pyridazine derivatives
11/13/2012US8309547 Processes for the preparation of rivaroxaban and intermediates thereof
11/13/2012US8309546 Morpholinopurine derivatives
11/13/2012US8309545 Benzofuran potassium channel blockers and uses thereof
11/13/2012US8309544 Spiroindalones
11/13/2012US8309543 Compositions useful as inhibitors of voltage-gated sodium channels
11/13/2012US8309542 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
11/13/2012US8309541 Anti-cancer compositions and methods
11/13/2012US8309540 HCV NS3 protease inhibitors
11/13/2012US8309539 Acute treatment of social phobia
11/13/2012US8309537 Compositions and methods for treating colitis
11/13/2012US8309535 Compositions and methods to treat recurrent medical conditions
11/13/2012US8309534 Compositions comprising a GPR109 ligand for treating disorders of the digestive tract and/or cancer
11/13/2012US8309533 Allele-specific RNA interference
11/13/2012US8309532 Therapeutic uses of inhibitors of RTP801
11/13/2012US8309527 For use as antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics
11/13/2012US8309526 Nitrated lipids and methods of making and using thereof
11/13/2012US8309356 Pseudocomplementary oligonucleotides for targeted gene therapy
11/13/2012US8309355 Methods of treating Parkinson's disease using viral vectors
11/13/2012US8309138 Pharmaceutical composition comprising microparticle oily suspension
11/13/2012US8309134 Modified calcium phosphate nanoparticle formation
11/13/2012US8309129 Nanoparticles comprising a drug, ethylcellulose, and a bile salt
11/13/2012US8309128 Stabilized milnacipran formulation
11/13/2012US8309127 Stable compositions of famotidine and ibuprofen
11/13/2012US8309126 Dispersible bosentan tablet
11/13/2012US8309125 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
11/13/2012US8309124 Delayed release tablet with defined core geometry
11/13/2012US8309122 Oxymorphone controlled release formulations
11/13/2012US8309121 Dermatological compositions comprising avermectin nanocapsules
11/13/2012US8309119 Drug containing adhesive preparation
11/13/2012US8309118 Mixture containing carrageenan, hydrocolloids; multilayer coatings
11/13/2012US8309111 High alcohol content foaming compositions with silicone-based surfactants
11/13/2012US8309110 Synergistic mixture of polyhexamethyleneguanidine phosphate and either 2-methyl-4-isothiazolone-3-one or 5-chloro-2-methyl-4-isothiazolone-3-one; high sterilizing effect, wide antibiotic spectrum; non-oxidizing and low foaming for industrial water treatment where metals susceptible to corrosion are used
11/13/2012US8309107 Stable solutions of orlistat for pharmaceutical dosage forms
11/13/2012US8309103 synergistic mixture; lower dosage; side-effect reduction
11/13/2012US8309097 C-type lectin binding molecules, identification and uses thereof
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012US8309073 Combination of probiotics
11/13/2012US8309062 Process for producing (3S)-I-menthyl 3-hydroxybutyrate and sensate composition
11/13/2012US8309061 Formulations and methods for treating rhinosinusitis
11/13/2012US8309060 Abuse-proofed dosage form
11/13/2012US8309053 Labeled fatty acid analogs; tissue-targeted therapy; tomography; block the catabolic pathway, thus trapping these analogs in a virtually unmodified form in the tissues of interest such as heart, liver, or tumor; endo-vinylic variants of cycloalkyl-substituted heptadecanoic acid for example
11/13/2012US8308795 Drug-delivery endovascular stent and method of forming the same
11/13/2012CA2776222A1 Hyaluronic acid esters, their preparation and use in dermatology
11/13/2012CA2715018C Vitamin e derivatives and their uses
11/13/2012CA2708043C Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
11/13/2012CA2690137C Polymorphic and other crystalline forms of cis-ftc
11/13/2012CA2680262C Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
11/13/2012CA2651353C Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form .alpha.
11/13/2012CA2579096C Quinazoline derivatives as metabolically inert antifolate compounds
11/13/2012CA2575758C Coenzyme q10-containing composition
11/13/2012CA2575396C Composition for capsule coating, capsule coating, and capsule using the same
11/13/2012CA2569993C Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
11/13/2012CA2549717C Compositions and methods for treating diabetes
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/13/2012CA2534314C Benzothiazole derivatives for the treatment of diabetes
11/13/2012CA2533747C Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/13/2012CA2518234C Thiolactones
11/13/2012CA2511925C Heterocyclic inhibitors of phosphatases, compositions and uses thereof
11/13/2012CA2508180C Dimetalhydroxy malates
1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 7860